These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 28074314

  • 1. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.
    Gargiulo L, May M, Rivero EM, Copsel S, Lamb C, Lydon J, Davio C, Lanari C, Lüthy IA, Bruzzone A.
    J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):43-57. PubMed ID: 28074314
    [Abstract] [Full Text] [Related]

  • 2. Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.
    Gargiulo L, Copsel S, Rivero EM, Galés C, Sénard JM, Lüthy IA, Davio C, Bruzzone A.
    Oncotarget; 2014 Oct 30; 5(20):10058-69. PubMed ID: 25375203
    [Abstract] [Full Text] [Related]

  • 3. The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells.
    Shi M, Liu D, Duan H, Qian L, Wang L, Niu L, Zhang H, Yong Z, Gong Z, Song L, Yu M, Hu M, Xia Q, Shen B, Guo N.
    Breast Cancer Res Treat; 2011 Jan 30; 125(2):351-62. PubMed ID: 20237834
    [Abstract] [Full Text] [Related]

  • 4. β2-AR signaling controls trastuzumab resistance-dependent pathway.
    Liu D, Yang Z, Wang T, Yang Z, Chen H, Hu Y, Hu C, Guo L, Deng Q, Liu Y, Yu M, Shi M, Du N, Guo N.
    Oncogene; 2016 Jan 07; 35(1):47-58. PubMed ID: 25798840
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O, Lattrich C, Springwald A, Ortmann O.
    Breast Cancer Res Treat; 2010 Apr 07; 120(3):557-65. PubMed ID: 19434490
    [Abstract] [Full Text] [Related]

  • 6. Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha.
    Lam L, Hu X, Aktary Z, Andrews DW, Pasdar M.
    Breast Cancer Res Treat; 2009 Dec 07; 118(3):605-21. PubMed ID: 19002577
    [Abstract] [Full Text] [Related]

  • 7. β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells.
    Liu D, Zha L, Liu Y, Zhao X, Xu X, Liu S, Ma W, Zheng J, Shi M.
    Cancer Sci; 2020 Dec 07; 111(12):4417-4428. PubMed ID: 33016509
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of exogenous androgen and an androgen receptor antagonist in the peri- and postpubertal murine mammary gland.
    Peters AA, Ingman WV, Tilley WD, Butler LM.
    Endocrinology; 2011 Oct 07; 152(10):3728-37. PubMed ID: 21846805
    [Abstract] [Full Text] [Related]

  • 9. New insights into fetal mammary gland morphogenesis: differential effects of natural and environmental estrogens.
    Speroni L, Voutilainen M, Mikkola ML, Klager SA, Schaeberle CM, Sonnenschein C, Soto AM.
    Sci Rep; 2017 Jan 19; 7():40806. PubMed ID: 28102330
    [Abstract] [Full Text] [Related]

  • 10. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
    Palaniappan M, Edwards D, Creighton CJ, Medina D, Conneely OM.
    PLoS One; 2018 Jan 19; 13(3):e0194913. PubMed ID: 29590203
    [Abstract] [Full Text] [Related]

  • 11. A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer.
    Liu D, Deng Q, Sun L, Wang T, Yang Z, Chen H, Guo L, Liu Y, Ma Y, Guo N, Shi M.
    BMC Cancer; 2015 Nov 02; 15():832. PubMed ID: 26526356
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.
    Xie D, Miller CW, O'Kelly J, Nakachi K, Sakashita A, Said JW, Gornbein J, Koeffler HP.
    J Biol Chem; 2001 Apr 27; 276(17):14187-94. PubMed ID: 11297518
    [Abstract] [Full Text] [Related]

  • 13. Estrogen regulation of thrombospondin-1 in human breast cancer cells.
    Hyder SM, Liang Y, Wu J.
    Int J Cancer; 2009 Sep 01; 125(5):1045-53. PubMed ID: 19391135
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rhodiola crenulata induces an early estrogenic response and reduces proliferation and tumorsphere formation over time in MCF7 breast cancer cells.
    Bassa LM, Jacobs C, Gregory K, Henchey E, Ser-Dolansky J, Schneider SS.
    Phytomedicine; 2016 Jan 15; 23(1):87-94. PubMed ID: 26850689
    [Abstract] [Full Text] [Related]

  • 16. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM.
    Cancer Res; 2001 Oct 15; 61(20):7456-63. PubMed ID: 11606380
    [Abstract] [Full Text] [Related]

  • 17. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA, Sager R, Webster L.
    Cancer Res; 1993 Oct 15; 53(20):5004-11. PubMed ID: 8402691
    [Abstract] [Full Text] [Related]

  • 18. STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland.
    Maia CJ, Socorro S, Schmitt F, Santos CR.
    Endocrine; 2008 Oct 15; 34(1-3):108-16. PubMed ID: 18958632
    [Abstract] [Full Text] [Related]

  • 19. Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β.
    Lazarus KA, Brown KA, Young MJ, Zhao Z, Coulson RS, Chand AL, Clyne CD.
    Endocrinology; 2014 May 15; 155(5):1606-17. PubMed ID: 24564400
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.